Recurrence of lymphoedema-associated cellulitis (erysipelas) under prophylactic antibiotherapy: a retrospective cohort study

Clicks: 386
ID: 119202
2006
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #5 of 18 articles by views in journal of the european academy of dermatology and venereology : jeadv

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Antibiotic prophylaxis using benzathin-penicillin is a well-tolerated treatment of erysipelas recurrence in patients with upper limb lymphoedema secondary to breast cancer. The rate of erysipelas recurrence was 26% at 1 year in patients who had a history of at least one erysipelas. We did not find a …
Reference Key
s2006journalrecurrence Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Vignes S;Dupuy A;;
Journal journal of the european academy of dermatology and venereology : jeadv
Year 2006
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/16898904
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine adult female aged middle aged Recurrence anti-bacterial agents / therapeutic use* antibiotic prophylaxis* a dupuy arm breast neoplasms / therapy erysipelas / etiology erysipelas / prevention & control* pmid:16898904 doi:10.1111/j.1468-3083.2006.01648.x s vignes lymphedema / etiology* penicillin g benzathine / therapeutic use*

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.